Abstract
Background Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a working diagnosis with several possible underlying causes. Early cardiovascular magnetic resonance imaging (CMR) is recommended, however cannot provide a diagnosis in 25% of cases. One pathophysiological mechanism may be coronary microvascular dysfunction (CMD) not possible to detect using standard CMR. Quantitative stress CMR perfusion mapping can be used to identify CMD, however it is currently unknown if CMD is present during long-term follow-up of MINOCA patients. Therefore, the aim of this study was to evaluate presence of CMD during long-term follow-up in MINOCA patients with an initial normal CMR scan.
Methods MINOCA patients from the second multicenter Stockholm Myocardial Infarction with Normal Coronaries study (SMINC-2), with a normal CMR scan a median 3 days after hospitalization were investigated with comprehensive stress CMR median 5 years after the acute event, together with age- and sex-matched volunteers without symptomatic ischemic heart disease. Cardiovascular risk factors, medication and symptoms of myocardial ischemia measured by the Seattle Angina Questionnaire 7, were registered.
Results In total, 15 patients with MINOCA and an initial normal CMR scan (59±7 years old, 60% female), and 15 age- and sex-matched volunteers, underwent CMR. Patients with MINOCA and an initial normal CMR scan had lower global stress perfusion compared to volunteers (2.83±1.8 vs 3.53±0.7 ml/min/g, p=0.02). There were no differences in other CMR parameters including global rest perfusion and myocardial perfusion reserve, hemodynamic parameters, or cardiovascular risk factors, except for a higher statin use in the MINOCA patient group compared to volunteers.
Conclusions Global stress perfusion is lower in MINOCA patients during follow-up, compared to age- and sex-matched volunteers, suggesting CMD as a possible pathophysiological mechanism in MINOCA.
Clinical Trial Registration Clinicaltrials.gov identifier NCT02318498. Registered 2014-12-17.
Competing Interest Statement
Nickander has previously received minor speaker compensation from Sanofi Genzyme AB for work unrelated to this study. The rest of the authors declare no relationships with industry.
Funding Statement
The study was funded by the Swedish Heart and Lung Foundation, Swedish Society of Medicine, Karolinska Institutet and Insamlingsstiftelsen Kvinnor och Halsa, all Stockholm, Sweden. Tornvall is funded by the Swedish Heart and Lung Foundation and the Swedish Research Council, Stockholm, Sweden. Sorensson is funded by the Swedish Heart and Lung Foundation. Nickander is funded by Karolinska Institutet and Region Stockholm, Sweden. Steffen Johansson is funded by Swedish Heart and Lung Foundation, Swedish Society of Medicine and Insamlingsstiftelsen Kvinnor och Halsa.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Swedish Ethical Review Authority gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Methods, results and discussion updated and clarified, figure 2 updated.
Data Availability
The data supporting the findings in this study are available from the corresponding author upon reasonable request.
Non-standard Abbreviations and Acronyms
- ACS
- Acute Coronary Syndrome
- CAD
- Coronary Artery Disease
- CMD
- Coronary Microvascular Dysfunction
- CMR
- Cardiac Magnetic Resonance Imaging
- ECV
- Extracellular Volume
- IHD
- Ischemic Heart Disease
- MI
- Myocardial Infarction
- MINOCA
- Myocardial Infarction with Non-obstructive Coronary Arteries
- MPR
- Myocardial Perfusion Reserve
